JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
B
3301
CALL
Barrick Mining
B
$67B
| $2.29M | ﹤0.01% |
+123,100
| New | +$2.21M |
2023 Q1
0 quarters
|
|
3302
CALL
First Solar
FSLR
$19.3B
| $2.28M | ﹤0.01% |
10,500
-300
| -3% | -$54.8K |
2022 Q3
2 quarters
|
|
|
TCVA
3303
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $2.28M | ﹤0.01% |
223,002
+23,002
| +12% | +$233K |
2022 Q3
2 quarters
|
|
|
HEES
3304
DELISTED
H&E Equipment Services
HEES
| $2.28M | ﹤0.01% |
51,636
-1,438
| -3% | -$70.1K |
2015 Q4
29 quarters
|
|
3305
Compass Minerals
CMP
$953M
| $2.28M | ﹤0.01% |
66,531
+10,934
| +20% | +$437K |
2015 Q4
29 quarters
|
|
3306
CALL
Teva Pharmaceutical Industries Limited
TEVA
$45.6B
| $2.27M | ﹤0.01% |
+256,900
| New | +$2.54M |
2023 Q1
0 quarters
|
|
3307
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$121M
| $2.27M | ﹤0.01% |
12,633
+4,957
| +65% | +$959K |
2021 Q2
7 quarters
|
|
3308
CALL
Danaher
DHR
$152B
| $2.27M | ﹤0.01% |
10,152
-71,515
| -88% | -$16.3M |
2021 Q2
7 quarters
|
|
3309
Roku
ROKU
$22.6B
| $2.27M | ﹤0.01% |
34,460
+21,580
| +168% | +$1.26M |
2018 Q1
20 quarters
|
|
3310
Kratos Defense & Security Solutions
KTOS
$8.21B
| $2.25M | ﹤0.01% |
167,274
-11,105
| -6% | -$132K |
2017 Q3
22 quarters
|
|
3311
Fidelity MSCI Industrials Index ETF
FIDU
$2.23B
| $2.25M | ﹤0.01% |
42,588
-23,905
| -36% | -$1.26M |
2022 Q4
1 quarter
|
|
|
ARIS
3312
DELISTED
Aris Water Solutions
ARIS
| $2.24M | ﹤0.01% |
287,523
+141,323
| +97% | +$1.82M |
2021 Q4
5 quarters
|
|
3313
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.84B
| $2.24M | ﹤0.01% |
47,807
+27,695
| +138% | +$1.28M |
2013 Q2
39 quarters
|
|
3314
National Healthcare
NHC
$3.58B
| $2.24M | ﹤0.01% |
38,526
+46
| +0.1% | +$2.64K |
2016 Q3
26 quarters
|
|
3315
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$806M
| $2.24M | ﹤0.01% |
211,550
+8,374
| +4% | +$88.3K |
2019 Q4
13 quarters
|
|
3316
Radware
RDWR
$1.29B
| $2.23M | ﹤0.01% |
103,661
-13,589
| -12% | -$284K |
2016 Q1
28 quarters
|
|
3317
PUT
American Airlines Group
AAL
$8.61B
| $2.23M | ﹤0.01% |
151,300
-442,700
| -75% | -$6.9M |
2014 Q3
34 quarters
|
|
3318
Bausch + Lomb
BLCO
$6.14B
| $2.23M | ﹤0.01% |
128,104
+2,319
| +2% | +$39.3K |
2022 Q4
1 quarter
|
|
3319
Fluence Energy
FLNC
$1.15B
| $2.23M | ﹤0.01% |
109,905
-34,762
| -24% | -$690K |
2021 Q4
5 quarters
|
|
|
AMRS
3320
DELISTED
Amyris Inc.
AMRS
| $2.23M | ﹤0.01% |
1,636,842
-474,068
| -22% | -$677K |
2018 Q1
20 quarters
|
|
|
MRTX
3321
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.23M | ﹤0.01% |
59,848
+16,842
| +39% | +$758K |
2018 Q2
19 quarters
|
|
|
FITB
3322
PUT
Fifth Third Bancorp
FITB
$46.3B
| $2.22M | ﹤0.01% |
83,500
+28,600
| +52% | +$950K |
2022 Q4
1 quarter
|
|
3323
Liberty Media Corporation Series A Common Stock
FWONA
$22B
| $2.21M | ﹤0.01% |
34,229
-253,513
| -88% | -$15.3M |
2013 Q2
39 quarters
|
|
3324
PUT
Marriott International
MAR
$94.2B
| $2.21M | ﹤0.01% |
13,300
-16,700
| -56% | -$2.78M |
2022 Q2
3 quarters
|
|
3325
Protolabs
PRLB
$2.33B
| $2.21M | ﹤0.01% |
66,528
+9,894
| +17% | +$306K |
2016 Q2
27 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.